NCT05705947

Brief Summary

The goal of this observational registry study is to collect data related to patient reported outcomes (pain, function, quality of life, toxicity) in osteoarthritis (OA) patients receiving standard of care radiation therapy (RT).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
52mo left

Started May 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
May 2023Dec 2030

First Submitted

Initial submission to the registry

January 20, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 31, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

May 31, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2025

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Expected
Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

2.5 years

First QC Date

January 20, 2023

Last Update Submit

January 27, 2026

Conditions

Keywords

Osteoarthritisradiation therapy

Outcome Measures

Primary Outcomes (1)

  • Change in Visual Analog Pain Scale (VAPS) Score from Baseline to M3 Post Radiation Treatment Completion

    The investigators will use the visual analog 0-10 pain scale (VAPS) and compare the baseline pre-radiation measurement to that measured at 3 months post radiation.

    Baseline and 3 months post RT

Secondary Outcomes (10)

  • Change in Visual Analog Pain Scale (VAPS) Score Over Time

    Baseline up to 5 years post RT

  • Change in Hip Joint-Specific Outcome Over Time

    Baseline up to 5 years post RT

  • Change in Knee Joint-Specific Outcome Over Time

    Baseline up to 5 years post RT

  • Change in Arm, Shoulder and Hand Joint-Specific Outcome Over Time

    Baseline up to 5 years post RT

  • Change in Foot Joint-Specific Outcome Over Time

    Baseline up to 5 years post RT

  • +5 more secondary outcomes

Study Arms (1)

Patients with osteoarthritis receiving radiation treatment

Patients with osteoarthritis receiving standard of care radiation treatment at UNC Radiation Oncology clinic. Radiation dose and fractionation prescription is at the physician's discretion. Typically, this prescription is delivered in 6 fractions, every other day, over 2 weeks.

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients, aged 55 or above, who are receiving radiation treatment at UNC Radiation Oncology for Osteoarthritis are the intended study population.

You may qualify if:

  • Willing and able to provide informed consent
  • Established diagnosis of OA of at least 1 joint
  • Inadequately controlled pain due to OA despite attempts with 2 or more other treatment modalities and Visual Analogue Pain Score of 4 or greater.
  • Will undergo radiation as part of their standard of care for OA.
  • At least 55 years old
  • Ability to read and speak English.

You may not qualify if:

  • Any woman who is pregnant or has reason to believe she is pregnant (the possibility of pregnancy has to be excluded by negative urine ß-HCG results, obtained within 2 weeks of CT simulation for radiation planning, or on the basis of patient history, e.g.: tubal ligation, hysterectomy or a minimum of 1 year without menses).
  • Estimated life expectancy less than 6 months.
  • Radiation treatment for shoulder OA
  • Patient weight greater than 550lbs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC Chapel Hill

Chapel Hill, North Carolina, 27514, United States

Location

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Theodore Yanagihara, MD, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2023

First Posted

January 31, 2023

Study Start

May 31, 2023

Primary Completion

December 11, 2025

Study Completion (Estimated)

December 1, 2030

Last Updated

January 29, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations